Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CHARLES CLEELAND and TITO R MENDOZA.
CHARLES CLEELAND
Connection Strength
13.275
TITO R MENDOZA
  1. The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. J Patient Rep Outcomes. 2020 Feb 19; 4(1):15.
    View in: PubMed
    Score: 0.749
  2. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). J Patient Rep Outcomes. 2019 Jun 17; 3(1):34.
    View in: PubMed
    Score: 0.715
  3. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain. 2015 Oct; 16(10):1032-43.
    View in: PubMed
    Score: 0.545
  4. Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain. 2012 Jun; 13(6):564-70.
    View in: PubMed
    Score: 0.436
  5. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27.
    View in: PubMed
    Score: 0.400
  6. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
    View in: PubMed
    Score: 0.395
  7. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006 May; 10(4):353-61.
    View in: PubMed
    Score: 0.273
  8. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain. 2004 Sep-Oct; 20(5):357-62.
    View in: PubMed
    Score: 0.256
  9. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004 May; 109(1-2):103-9.
    View in: PubMed
    Score: 0.251
  10. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
    View in: PubMed
    Score: 0.223
  11. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Support Care Cancer. 2021 Oct; 29(10):6099-6107.
    View in: PubMed
    Score: 0.202
  12. Development and Validation of a Patient-reported Outcome Measure for Gastrointestinal Obstruction in the Setting of Advanced Malignancy. Ann Surg. 2022 Dec 01; 276(6):e805-e811.
    View in: PubMed
    Score: 0.199
  13. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.195
  14. Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints. Med Care. 2019 05; 57 Suppl 5 Suppl 1:S8-S12.
    View in: PubMed
    Score: 0.177
  15. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
    View in: PubMed
    Score: 0.177
  16. Assessment of baseline symptom burden in treatment-na?ve patients with lung cancer: an observational study. Support Care Cancer. 2019 Sep; 27(9):3439-3447.
    View in: PubMed
    Score: 0.174
  17. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res. 2018 Dec; 27(12):3229-3241.
    View in: PubMed
    Score: 0.169
  18. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028.
    View in: PubMed
    Score: 0.168
  19. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017 06; 158(6):1108-1112.
    View in: PubMed
    Score: 0.155
  20. Validation of the Persian Version of the Brief Pain Inventory (BPI-P) in Chronic Pain Patients. J Pain Symptom Manage. 2017 07; 54(1):132-138.e2.
    View in: PubMed
    Score: 0.154
  21. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
    View in: PubMed
    Score: 0.153
  22. Validity and reliability of a Turkish Brief Pain Inventory Short Form when used to evaluate musculoskeletal pain. J Back Musculoskelet Rehabil. 2017; 30(2):229-233.
    View in: PubMed
    Score: 0.151
  23. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751.
    View in: PubMed
    Score: 0.148
  24. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. Eur J Cancer. 2016 11; 67:83-90.
    View in: PubMed
    Score: 0.148
  25. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology. 2016; 90(3):127-35.
    View in: PubMed
    Score: 0.142
  26. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. J Pain Symptom Manage. 2016 06; 51(6):1055-61.
    View in: PubMed
    Score: 0.142
  27. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer. 2015 Apr 01; 121(7):1138-46.
    View in: PubMed
    Score: 0.130
  28. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73.
    View in: PubMed
    Score: 0.130
  29. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32.
    View in: PubMed
    Score: 0.123
  30. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 01; 20(5):1366-74.
    View in: PubMed
    Score: 0.123
  31. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer. 2014 Feb; 12(1):41-9.
    View in: PubMed
    Score: 0.121
  32. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40.
    View in: PubMed
    Score: 0.120
  33. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer. 2013 Oct; 13(5):325-34.
    View in: PubMed
    Score: 0.118
  34. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8.
    View in: PubMed
    Score: 0.117
  35. Authors' reply to Tendas et al. J Pain Symptom Manage. 2013 Apr; 45(4):e3-4.
    View in: PubMed
    Score: 0.116
  36. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9.
    View in: PubMed
    Score: 0.116
  37. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013 Feb 05; 6:13.
    View in: PubMed
    Score: 0.115
  38. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res. 2013 Oct; 22(8):2143-50.
    View in: PubMed
    Score: 0.115
  39. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012 Aug; 44(2):168-80.
    View in: PubMed
    Score: 0.110
  40. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012 Jun 01; 30(16):1980-8.
    View in: PubMed
    Score: 0.109
  41. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 2012 Oct 15; 118(20):5026-37.
    View in: PubMed
    Score: 0.108
  42. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
    View in: PubMed
    Score: 0.103
  43. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.
    View in: PubMed
    Score: 0.100
  44. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011 Jul 15; 117(14):3222-8.
    View in: PubMed
    Score: 0.100
  45. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9.
    View in: PubMed
    Score: 0.098
  46. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9.
    View in: PubMed
    Score: 0.096
  47. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010 Apr 15; 116(8):2053-63.
    View in: PubMed
    Score: 0.095
  48. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine. 2010 Apr; 12(4):421-30.
    View in: PubMed
    Score: 0.094
  49. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010 Jan 01; 116(1):137-45.
    View in: PubMed
    Score: 0.093
  50. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology. 2009; 76(1):59-68.
    View in: PubMed
    Score: 0.086
  51. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.084
  52. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage. 2009 Mar; 37(3):331-40.
    View in: PubMed
    Score: 0.084
  53. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
    View in: PubMed
    Score: 0.083
  54. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008 Oct; 36(4):367-73.
    View in: PubMed
    Score: 0.083
  55. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage. 2008 Sep; 36(3):259-67.
    View in: PubMed
    Score: 0.082
  56. Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Palliat Care Pharmacother. 2008; 22(1):7-20.
    View in: PubMed
    Score: 0.081
  57. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
    View in: PubMed
    Score: 0.079
  58. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76.
    View in: PubMed
    Score: 0.076
  59. An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7.
    View in: PubMed
    Score: 0.075
  60. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
    View in: PubMed
    Score: 0.073
  61. Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006 Jul 01; 107(1):207-14.
    View in: PubMed
    Score: 0.073
  62. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52.
    View in: PubMed
    Score: 0.072
  63. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006 Jan; 7(1):49-56.
    View in: PubMed
    Score: 0.070
  64. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72.
    View in: PubMed
    Score: 0.066
  65. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25.
    View in: PubMed
    Score: 0.065
  66. Perceptions of analgesic use and side effects: what the public values in pain management. J Pain Symptom Manage. 2004 Nov; 28(5):460-73.
    View in: PubMed
    Score: 0.065
  67. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
    View in: PubMed
    Score: 0.065
  68. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004 Sep-Oct; 20(5):309-18.
    View in: PubMed
    Score: 0.064
  69. The analgesic effects that underlie patient satisfaction with treatment. Pain. 2004 Jul; 110(1-2):480-7.
    View in: PubMed
    Score: 0.063
  70. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
    View in: PubMed
    Score: 0.062
  71. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10.
    View in: PubMed
    Score: 0.061
  72. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44.
    View in: PubMed
    Score: 0.061
  73. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain? J Natl Compr Canc Netw. 2023 11; 21(11):1132-1140.e3.
    View in: PubMed
    Score: 0.061
  74. Pain and fatigue in community-dwelling adults. Pain Med. 2003 Sep; 4(3):231-7.
    View in: PubMed
    Score: 0.060
  75. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59.
    View in: PubMed
    Score: 0.059
  76. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes. 2023 05 26; 7(1):48.
    View in: PubMed
    Score: 0.059
  77. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage. 2003 May; 25(5):449-58.
    View in: PubMed
    Score: 0.058
  78. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18.
    View in: PubMed
    Score: 0.058
  79. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol. 2023 05; 201(4):738-746.
    View in: PubMed
    Score: 0.057
  80. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002 Apr 15; 94(8):2295-304.
    View in: PubMed
    Score: 0.054
  81. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002 Mar 01; 20(5):1319-28.
    View in: PubMed
    Score: 0.054
  82. Effects of patient-reported outcome assessment order. Clin Trials. 2022 06; 19(3):307-315.
    View in: PubMed
    Score: 0.054
  83. Identification of Breast Cancer Survivors With High Symptom Burden. Cancer Nurs. 2022 Jul-Aug 01; 45(4):253-261.
    View in: PubMed
    Score: 0.053
  84. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021 02; 18(1):104-114.
    View in: PubMed
    Score: 0.049
  85. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module. Neurooncol Pract. 2021 Apr; 8(2):137-147.
    View in: PubMed
    Score: 0.049
  86. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Jpn J Clin Oncol. 2020 Jul 09; 50(7):787-793.
    View in: PubMed
    Score: 0.048
  87. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer. JCO Oncol Pract. 2020 10; 16(10):e1151-e1160.
    View in: PubMed
    Score: 0.048
  88. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer. J Pain Symptom Manage. 2020 05; 59(5):1052-1058.e1.
    View in: PubMed
    Score: 0.047
  89. Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 08; 38(4):1166-1174.
    View in: PubMed
    Score: 0.046
  90. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790.
    View in: PubMed
    Score: 0.046
  91. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):100-107.
    View in: PubMed
    Score: 0.046
  92. Patient-reported outcomes in light of supportive medications in treatment-na?ve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816.
    View in: PubMed
    Score: 0.045
  93. Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Hum Factors. 2018 Jul 16; 5(3):e10070.
    View in: PubMed
    Score: 0.042
  94. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 11 23; 12(1):186.
    View in: PubMed
    Score: 0.040
  95. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.040
  96. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 2016 Nov 15; 122(21):3401-3409.
    View in: PubMed
    Score: 0.036
  97. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module. Balkan Med J. 2016 May; 33(3):339-43.
    View in: PubMed
    Score: 0.036
  98. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92.
    View in: PubMed
    Score: 0.036
  99. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1107-14.
    View in: PubMed
    Score: 0.035
  100. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
    View in: PubMed
    Score: 0.035
  101. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8.
    View in: PubMed
    Score: 0.034
  102. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. Biol Blood Marrow Transplant. 2016 Feb; 22(2):226-231.
    View in: PubMed
    Score: 0.034
  103. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-284.
    View in: PubMed
    Score: 0.034
  104. Automated pain intervention for underserved minority women with breast cancer. Cancer. 2015 Jun 01; 121(11):1882-90.
    View in: PubMed
    Score: 0.033
  105. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015 May; 56(5):1335-41.
    View in: PubMed
    Score: 0.033
  106. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.032
  107. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26.
    View in: PubMed
    Score: 0.032
  108. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84.
    View in: PubMed
    Score: 0.031
  109. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14.
    View in: PubMed
    Score: 0.031
  110. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 01; 122(5):641-7.
    View in: PubMed
    Score: 0.029
  111. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1531-40.
    View in: PubMed
    Score: 0.029
  112. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8.
    View in: PubMed
    Score: 0.028
  113. Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum Clin Oncol. 2012 Mar; 3(1):29-31.
    View in: PubMed
    Score: 0.027
  114. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):587-99.
    View in: PubMed
    Score: 0.026
  115. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011 Mar; 41(3):558-65.
    View in: PubMed
    Score: 0.025
  116. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9.
    View in: PubMed
    Score: 0.025
  117. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86.
    View in: PubMed
    Score: 0.024
  118. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.024
  119. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010 Mar; 11(3):337-46.
    View in: PubMed
    Score: 0.023
  120. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):775-81.
    View in: PubMed
    Score: 0.022
  121. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail. 2008 Aug; 14(6):497-507.
    View in: PubMed
    Score: 0.021
  122. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage. 2008 Jan; 35(1):95-102.
    View in: PubMed
    Score: 0.020
  123. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6.
    View in: PubMed
    Score: 0.020
  124. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8.
    View in: PubMed
    Score: 0.019
  125. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
    View in: PubMed
    Score: 0.018
  126. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52.
    View in: PubMed
    Score: 0.018
  127. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53.
    View in: PubMed
    Score: 0.017
  128. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
    View in: PubMed
    Score: 0.016
  129. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 Feb 07; 25(3):94-102.
    View in: PubMed
    Score: 0.015
  130. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42.
    View in: PubMed
    Score: 0.015
  131. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104.
    View in: PubMed
    Score: 0.015
  132. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003 Feb; 25(2):106-17.
    View in: PubMed
    Score: 0.014
  133. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002 Nov; 24(5):517-25.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.